1. Does endometrial integrin expression in endometriosis patients predict enhanced in vitro fertilization cycle outcomes after prolonged GnRH agonist therapy? 
Eric S. Surrey, M.D., Annette K. Lietz, L.V.N., Robert L. Gustofson, M.D., Debra A. Minjarez, M.D., William B. Schoolcraft, M.D. 
Fertility and Sterility 
Volume 93, Issue 2, Pages (January 2010)
DOI: /j.fertnstert
Copyright © 2010 American Society for Reproductive Medicine Terms and Conditions

2. Figure 1
Randomization summary of patients eligible to participate in the current trial.
Fertility and Sterility  , DOI: ( /j.fertnstert )
Copyright © 2010 American Society for Reproductive Medicine Terms and Conditions

3. Figure 2
Biochemical (Bio), ongoing pregnancy (OPR), and implantation (IR) rates in Groups 1 and 2 with positive endometrial αvβ3 vitronectin expression.
Fertility and Sterility  , DOI: ( /j.fertnstert )
Copyright © 2010 American Society for Reproductive Medicine Terms and Conditions

4. Figure 3
Biochemical (Bio), ongoing pregnancy (OPR), and implantation (IR) rates in Groups A and B with negative αvβ3 vitronectin expression.
Fertility and Sterility  , DOI: ( /j.fertnstert )
Copyright © 2010 American Society for Reproductive Medicine Terms and Conditions